The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit research organisation dedicated to the coordination of research projects. It aims to support the development of biomedical imaging technologies and the dissemination of knowledge. It was established on the initiative of The European Society of Radiology (ESR) in 2006 and funded by the European Commission within Framework Programme 6. EIBIR’s mission is to improve cooperation within the European biomedical imaging community, with the goal of improving the diagnosis, treatment, and prevention of diseases. The organisation actively supports research networking activities, common initiatives, and interoperability in the field of biomedical imaging research by providing services in proposal writing, project management and taking the lead in dissemination and communication activities.

EIBIR in HyperProbe

EIBIR leads WP7: Dissemination, communication and exploitation and WP8: Project Management. This includes the development of a strategy for all communication and dissemination activities, and the development of dedicated communication and dissemination material as part of Work Package 7. Additionally, EIBIR is also responsible for establishing the HyperProbe project management structure, quality assurance, risk management, as well as handling the day-to-day administative and reporting duties of the project.

Peter Gordebeke

Peter Gordebeke graduated with a Master’s degree in Medical Biology from Radboud University Nijmegen, Netherlands. He has experience in small non-coding RNA and micro RNA research and spent time in the pharmaceutical industry establishing new molecular testing methods, including the validation of critical testing equipment.

Since joining EIBIR in 2014, he as been involved in several EU-funded research projects in various capacities, ranging from coordination to project management and leading the communication and dissemination aspects.

Peter currently serves as the main coordinator contact for the EUCAIM project (Cancer Image Europe) and the ODELIA project. He is the project manager for the Alternatives To Gd and Med-IPUT projects and shares this role with his colleague Katharina for the HyperProbe project. Peter is the lead communication and dissemination manager for EuCanImage and RadioVal.

In addition, Peter lead the data management and collection activities within EIBIR.

Katharina Krischak

Katharina holds Master’s degrees in English, German Philology, and Celtic Studies from the University of Vienna. Prior to joining the EIBIR team in August 2014, she gained experience working at the European Commission in Brussels and the Council of Europe in Strasbourg.

Katharina has over 8 years of experience in managing and disseminating the results of EU-funded projects, including Horizon Europe, Horizon 2020 and COST actions. She is currently involved in the coordination and dissemination of several projects. Within HyperProbe, Katharina co-leads the project management and dissemination tasks. In addition, she coordinates the EURAMED rocc-n-roll (European Medical Application and Radiation Protection Concept: Strategic Research Agenda and Roadmap Interlinking Health and Digitisation Aspects) and ODELIA (An Open Consortium for Decentralized Medical Artificial Intelligence) projects and serves as work package leader for dissemination in the CHAIMELEON (Accelerating the lab to market transition of AI tools for cancer management) project.

 

Eszter Balazs

Eszter joined the EIBIR team in November 2022 as a Junior Project Manager.  She has experience in EU tender coordination, project management, communication activities and EU affairs.

She graduated with a master’s degree in Global Political Economy from the University of Bristol and finished her undergraduate studies in Economics and Politics at the University of Exeter.

She is currently involved with the coordination and management of the HyperProbe project, and supports the management and dissemination of several additional Horizon Europe projects, including RadioVal and ODELIA.